Results 261 to 270 of about 122,773 (309)

Troglitazone: an antidiabetic agent

American Journal of Health-System Pharmacy, 1998
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of troglitazone are reviewed. Troglitazone is the first oral thiazolidinedione approved for use in treating non-insulin-dependent diabetes mellitus (NIDDM). The drug's mechanism of action has not been fully elucidated.
openaire   +2 more sources

Antidiabetics

Reactions Weekly, 2022
openaire   +1 more source

ANTIDIABETIC EFFECTS OF LITHIUM

The Lancet, 1972
P, Männistö, V, Koivisto
openaire   +4 more sources

Flavonoids as Antidiabetic and Anti-Inflammatory Agents: A Review on Structural Activity Relationship-Based Studies and Meta-Analysis

International Journal of Molecular Sciences, 2022
Nur Farisya Shamsudin, Qamar Uddin Ahmed
exaly  

Oral Antidiabetic Therapy

Acta Medica Scandinavica, 1982
A, Melander, L O, Almér, G, Sartor, B, Scherstén, E, Wåhlin-Boll   +4 more
openaire   +2 more sources

Activity, structural features and in silico digestion of antidiabetic peptides

Food Bioscience, 2023
Carmen Berraquero-Garcia, Fernando Rivero-Pino, Raúl Pérez-Gálvez   +2 more
exaly  

Screening of novel potential antidiabetic Lactobacillus plantarum strains based on in vitro and in vivo investigations

LWT - Food Science and Technology, 2021
Hao Zhong, Minjie Zhao, Junhui Zhang
exaly  

ANTIDIABETIC DIETS

BMJ, 1931
openaire   +2 more sources

Antidiabetics

Reactions Weekly, 2019
openaire   +1 more source

Antidiabetic potential of anthraquinones: A review

Phytotherapy Research, 2020
Aminu Mohammed, Mohammed Auwal Ibrahim, Nasir Tajuddeen   +2 more
exaly